India has five drug manufacturing companies under public sector. The basic idea behind the Indian government creating these public sector undertakings or PSUs in India’s health sector is to check the possible monopolistic practices by the leading, privately-held drug makers and to ensure affordability of certain essential medicines to the larger public.
India’s PSU drug companies produce pharmaceuticals like tablets, injectables and other medical products to various public health institutions and defence.
What I have here are brief profiles of those five drug PSU companies in India viz., Indian Drugs and Pharmaceuticals Ltd (IDPL), Bengal Chemical and Pharmaceuticals Ltd (BCPL), Rajasthan Drugs and Pharmaceuticals Ltd (RDPL), Karnataka Antibiotics and Pharmaceuticals Ltd (KAPL) & Hindustan Antibiotics Limited.
IDPL is the largest Central Pharma Public Sector Undertaking in India. IDPL has manufacturing plants at Rishikesh, Gurgaon, Chennai, Hyderabad and Muzaffarpur.
Indian Drugs and Pharmaceuticals Ltd (IDPL) is the largest Central Pharma Public Sector Undertaking in India. Established in 1961, IDPL’s birth control pills Mala-D & Mala-N are quite popular in rural parts of India.
IDPL develops new drugs and formulations and high yielding strains for antibiotics from its two R&D centres at Hyderabad and Rishikesh. IDPL claims to be the first pharma company in India to make Vitamin B6 using its own technology. The public sector drug manufacturer has also developed in-house technologies for production of Methyl Dopa and Chloroquine Phosphate.
One of IDPL’s non-steroidal, anti-inflammatory and anti-arthritic compounds has completed last stage ie., phase-III clinical trials. Three more promising candidates from this public sector drug manufacturer are in advanced stage of biological evaluation.
IDPL is one of the major pharma suppliers to Defence, ESIC and Ministry of Health. Institutional sales in India form the bulk of IDPL’s sales volume.
Latest news abut IDPL, PSU drug company in India
Founded in the year 1901, Bengal Chemical & Pharmaceutical Works Ltd (BCPW) is considered the first pharmaceutical company in India. Dr Prafulla Chandra Ray started it as a small private concern in Upper Circular Road, Kolkota and manufactured drugs from indigenous materials.
BCPL has 4 factories – 2 in West Bengal, 1 in Mumbai and 1 in Kanpur. It has sales outlets in 11 cities, and a wide distribution network all over India and abroad with more than 1500 distributors. This pubic sector drug manufacturer has a good infrastructure and huge surplus land.
BCPL now boasts of wide range of offerings including industrial chemicals, bulk drugs, perfumeries, toiletries, hospitals and surgical equipment, sera, vaccine and fire extinguisher among others.
Headquartered in Jaipur, Rajasthan Drugs and Pharmaceuticals Ltd (RDPL) is a subsidiary of Indian Drugs and Pharmaceuticals Ltd (IDPL). IDPL holds 51.12% in the company.
Rajasthan Drugs & Pharmaceuticals Limited was incorporated in 1978 under the Indian Companies Act, 1956 as a joint venture company with Rajasthan State Industrial Development and Investment Corporation Limited and Indian Drugs and Pharmaceuticals’ Limited. The purpose of creating RDPL was to supply life-saving and other essential drugs to the various government organizations. It is a Schedule ‘D’ “Mini Ratna” Centrally Owned Public Sector Enterprise (CPSE) under the administrative control of Department of Chemicals and Petrochemicals, Ministry of Chemicals & Fertilizers.
RDPL has registered fairly good growth over the period and especially during the last ten years when the turnover rose from Rs. 894.00 lakhs in 1994-95 to Rs 1912.00 lakhs in 2003-2004. The authorized and paid up capital of the public sector drug manufacturer is Rs. 2 crore and Rs. 1.07 crore respectively as on March 31, 2008. RDPL proposes to upgrade and modernize its existing manufacturing facilities at an estimated cost of Rs. 8.75 crore.
Karnataka Antibiotics & Pharmaceuticals Ltd (KAPL) is a joint venture company promoted by Hindustan Antibiotics Ltd (HAL) and State Government of Karnataka through Karnataka State Industrial & Investment Development Corporation (KSIIDC).
KAPL now plans to upgrade its manufacturing facilities and also set up a new cephalasporin – a new generation antibiotic – plant at an estimated cost of Rs. 22.45 crore.
Like Rajasthan Drugs & Pharmaceuticals Limited, KAPL is also a profit-making public sector pharma company. KAPL website
Hindustan Antibiotics Limited (HAL) is the first drug manufacturing company to be set up in the public sector by Government of India with active co-operation of WHO and UNICEF.
Set up on 10th March, 1954, HAL is the first drug manufacturing unit in India to undertake commercial production of antibiotics like Penicillin, Streptomycin, Gentamycin, Ampicillin & Amoxycillin etc. HAL has diversified in formulation activity and has facility to manufacture various dosage forms – injectables, capsules, tablets, large volume parenterals, liquid orals, etc. conforming to pharmacopoeial standards. HAL has also diversified into agro-vet products.
Hindustan Antibiotics Limited claims the rare distinction of being the only laboratory in the public sector in India which has come out with its own discoveries viz. Hamycin for skin infections and Aureofungin for plant fungal control.
To promote affordable drugs throughout India, Hindustan Antibiotics Limited (HAL) has set-up two subsidiary companies – Maharashtra Antibiotics & Pharmaceuticals Ltd and Karnataka Antibiotics & Pharmaceuticals Ltd. HAL’s export formulations plant have the WHO approval for good manufacturing practices (GMP). HAL’s manufacturing unit is situated at Pimpri, an industrial suburb in the city of Pune, which is 160 km south-west of Mumbai in India.
HAL claims to be the first pharma company in India to launch a recombinant DNA product, rHU-Erythropoietin (Hemax) in 1993. Presently, part of HAL’s fermentation manufacturing facility has been leased to RPG Life Sciences (RPGLS) for manufacture of Vitamin B-2 / B-12.
HAL has entered into a technical agreement with India’s biggest vaccine maker Serum Institute of India Limited for manufacture of the Plasma Volume Expander made from polymerised gelatin – Polygeline 3.5%
HAL’s bulk manufacturing facility includes a plant for manufacturing Benzathine Penicillin, Procaine Penicillin and Sodium Penicillin etc. The plant has the annual capacity to produce 12 MMU of Benzathine Penicillin, 24 MMU of Procaine Penicillin and 24 MMU of Sodium Penicillin.
Dry powder injectables: Facility includes the State-of-the art automatic powder injectable line from Robert Bosch (FRG) with the line speed of 300 vials/min includes all operation right from washing to packing line. Annual plant capacity is 132 Million vials.
Large volume parenterals (LVP): The facility also includes the state-of-the-art blow fill seal machines from Rommelag (Switzerland) and Autoclaves of Gettenge make.
Annual plant capacity is 12 million bottles/annum in 100 Ml / 540 Ml.
Tablet facilities: Tablet facility includes 45 station Manesty compression Machines, 27 station and 16 station compression machines with matching packing capacities for blister packing or strip packing. Capsule facility includes two state-of-the-art automatic capsule filling machines, Robert Bosch(FRP) make with the production rate of 1500 capsules/min. The annual plant capacity is 120 million penicillin capsules, 130 million non-penicillin capsules and 120 million penicillin tablets
Agriculture facility includes two state-of-the-art automatic pouch filling machines, of Ganson make with the production rate of 35 pouches/min. Annual plant capacity is 48 lakhs/year
D. Liquid Syrup: Liquid syrup facility include automatic filling, sealing and labelling machine with the production rate of 120 bottles/min. Annual plant capacity is 24 lakhs/year.
HAL is also into dignostics kits business.